<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJRad</journal-id><journal-title-group><journal-title>Open Journal of Radiology</journal-title></journal-title-group><issn pub-type="epub">2164-3024</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojrad.2021.114014</article-id><article-id pub-id-type="publisher-id">OJRad-113385</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Physics&amp;Mathematics</subject></subj-group></article-categories><title-group><article-title>
 
 
  Contribution of MRI in Extension Assessment of Cervical Cancer in Yaound&#233; (Cameroon)
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mbozo’o</surname><given-names>Mvondo Samuel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yannick</surname><given-names>Onana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aminou</surname><given-names>Mohamadou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jérémie</surname><given-names>Mbo Amvene</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>David</surname><given-names>Ngaroua</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Genesis</surname><given-names>Eric Secvou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mathurin</surname><given-names>Neossi Guena</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Obi</surname><given-names>Fidelis Ayuk</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ekobena</surname><given-names>Fouda</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Odile</surname><given-names>Fernade Zeh</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Boniface</surname><given-names>Moifo</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hamadou</surname><given-names>Ba</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Samuel</surname><given-names>Nko’o Amvene</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Departement of Radiology and Medical Imaging, Faculty of Medicine and Biomedical Sciences of Garoua, University of Ngaoundéré, Ngaoundéré, Cameroon</addr-line></aff><aff id="aff4"><addr-line>Faculty of Medicine and Biomedical Sciences, University of Yaoundé, Cameroon</addr-line></aff><aff id="aff3"><addr-line>Department of Radiology, Yaoundé Military Hospital, Yaoundé, Cameroon</addr-line></aff><aff id="aff2"><addr-line>Department of Biomedical Sciences, Faculty of Sciences, University of Ngaoundéré, Ngaoundéré, Cameroon</addr-line></aff><pub-date pub-type="epub"><day>27</day><month>10</month><year>2021</year></pub-date><volume>11</volume><issue>04</issue><fpage>151</fpage><lpage>159</lpage><history><date date-type="received"><day>12,</day>	<month>September</month>	<year>2021</year></date><date date-type="rev-recd"><day>22,</day>	<month>November</month>	<year>2021</year>	</date><date date-type="accepted"><day>25,</day>	<month>November</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Cervical cancer is one of the most common cancers, requiring a precise complementary assessment. The aim of this study was to contribute to the improvement of the management of cervical cancer by describing the MRI aspects of cervical cancer according to the IFOG-MRI classification. 
  Material and Methods: This was a cross-sectional study, conducted in patients who came for clinical suspicion, extension assessment of histologically confirmed cervical cancer, from October 2020 to March 2021, in Yaound&#233; (Cameroon). 
  Results: 54 patients were selected, with an average age of 50.4 years. Genital hemorrhage was the most frequent symptom (92%). The mean tumor size was 52.9 mm. According to IFOG staging, stages Ia, Ib, IIa, IIb, IIIa, IIIb, and IV accounted for 9.10%, 10.20%, 12.50%, 29.50%, 5.70%, 12.50%, and 20% respectively. No patient had known metastasis at the time of examination. 
  Conclusion: MRI allows non-invasive, satisfactory tumor staging examination by providing information on tumor size, parametrium invasion, adjacent organ involvement, and the presence of lymph node metastasis.
 
</p></abstract><kwd-group><kwd>Cervical Cancer</kwd><kwd> Magnetic Resonance Imaging</kwd><kwd> International Federation of Obstetricians and Gynecologists</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Cervical cancer is one of the most common cancers, responsible for nearly 10 million deaths in 2020 according to the data of World Health Organization [<xref ref-type="bibr" rid="scirp.113385-ref1">1</xref>]. It is also a public health problem in developing countries, especially in sub-Saharan Africa where it occupies the first rank among women’s cancers [<xref ref-type="bibr" rid="scirp.113385-ref2">2</xref>]. In Cameroon, in 2018, there were an estimated 2350 cervical cancers and 1540 deaths per year, according to the data of GLOBOCAN [<xref ref-type="bibr" rid="scirp.113385-ref3">3</xref>].</p><p>The occurrence of cervical cancer is primarily related to infection with oncogenic Human Papillomavirus (HPV). Other predisposing factors include early sexuality, multiple sexual partners, early conception, smoking, and immunosuppression [<xref ref-type="bibr" rid="scirp.113385-ref4">4</xref>].</p><p>The staging of the disease has always been determined by the International Federation of Obstetricians and Gynecologists (IFOG) classification, which does not take into account some important parameters such as lymph node involvement [<xref ref-type="bibr" rid="scirp.113385-ref5">5</xref>].</p><p>Very often, the prognosis remains poor due to late diagnosis and treatment that is often inappropriate to the stage of the disease that could have been done by earlier MRI [<xref ref-type="bibr" rid="scirp.113385-ref2">2</xref>].</p><p>Though the MRI remains a very cost and difficult accessible exam in our country, does it efficiently participate in the management of cervical cancer?</p><p>With the general aim of participating in the improvement of cervical cancer management in Cameroon, this study was carried out to precise the role of pelvic Magnetic Resonance Imaging (MRI) for the characterization of the tumor, its local and lymph node extension and its complementarity to the IFOG classification in Cameroon [<xref ref-type="bibr" rid="scirp.113385-ref6">6</xref>].</p></sec><sec id="s2"><title>2. Material and Methods</title><sec id="s2_1"><title>2.1. Type of Study</title><p>It was a cross-sectional, descriptive study, over a period of 6 months (from October 8, 2020 to March 21, 2021), carried out in the Radiology and Medical Imaging Department of the Military Hospital of Yaound&#233; (HMY).</p></sec><sec id="s2_2"><title>2.2. Study Population</title><p>The population consisted of patients admitted to the MRI department of the Yaounde Military Hospital (YMH) for pelvic or abdominal-pelvic MRI for clinical suspicion, or extension assessment of histologically confirmed cervical cancer, or for follow-up of treated cervical cancer. Patients with known renal insufficiency or contraindication to contrast media injection were excluded from our study.</p></sec><sec id="s2_3"><title>2.3. Procedure</title><p>The magnetic resonance imaging protocol included T2 Blade sequences in the three planes, T1 Dixon, T1 FS, diffusion, axial and coronal TSE T2 sequences on the abdomen (lymph node exploration), as well as T1FS sequences in the three planes after contrast injection. The slice thickness was 4 - 5 mm, and the field of exploration covered from the recto-sigmoid hinge to the pubic symphysis, including the iliac lymph nodes. The injected contrast medium was 50 cc of Gadolinium chelates.</p><p>We retrieved from the medical records on presenting complaints, initial clinical examination, MRI reports and images.</p><p>All MRI were reviewed by experienced radiologists.</p></sec><sec id="s2_4"><title>2.4. Variables</title><p>The primary variables in this study were the pelvic MRI result. The imaging data collected were the presence of the tumor, its size, and the characterization of the tumor stage according to the IFOG classification [<xref ref-type="bibr" rid="scirp.113385-ref5">5</xref>] as well as lymph node involvement.</p><p>A tumor localized to the cervix was considered as stage I, a tumor with extension to parametrium and/or to the upper 1/3 of the vagina was stage II tumor, a tumor reaching the pelvic wall and/or lower 1/3 of the vagina and/or with presence of hydronephrosis was a stage III tumor, and the tumor with extension beyond the pelvis or attenuating the bladder and/or rectum was a stage IV tumor [<xref ref-type="bibr" rid="scirp.113385-ref5">5</xref>].</p><p>Secondary variables were socio-demographic data (age, geographical distribution, marital status, occupation), and clinical signs and symptoms.</p></sec><sec id="s2_5"><title>2.5. Statistical Analysis</title><p>The data collected was processed through the following software: Microsoft Excel 2016 and IBM SPSS 23. The results are expressed in tables and figures, as mean and percentage.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Study Population</title><p>A total of 54 patients were included in our study, with a mean age of 50.5 years. The most represented age group was 50 - 64 years (38.90%, n = 21), as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. 55.60% (n = 30) of these patients lived in rural area, 59.6% (n = 31) of them were married, and 25% (n = 15) were widows. Housewives represented 51.9% of the patients (n = 28).</p></sec><sec id="s3_2"><title>3.2. Clinical Data</title><p>The vast majority of our patients (55%, n = 30) consulted on average 6 months after the onset of symptoms.</p><p><xref ref-type="table" rid="table1">Table 1</xref> shows the different functional signs, which were dominated by metrorragia (92.5%, n = 50).</p></sec><sec id="s3_3"><title>3.3. Pelvic MRI Findings</title><p><xref ref-type="fig" rid="fig2">Figure 2</xref> summarizes the IFOG tumor stages obtained in the 54 patients of our study population. Stage IIB was the most encountered (29.5%, n = 26).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of cases by clinical signs</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Clinical manifestations</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Metrorragia</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >92.5%</td></tr><tr><td align="center" valign="middle" >Pelvic pain</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >26.7%</td></tr><tr><td align="center" valign="middle" >Leucorrhoea</td><td align="center" valign="middle" >08</td><td align="center" valign="middle" >15.7%</td></tr><tr><td align="center" valign="middle" >Other signs</td><td align="center" valign="middle" >06</td><td align="center" valign="middle" >11.1%</td></tr></tbody></table></table-wrap><p>Tumors limited to the cervix accounted for 26.7% (n = 14). Parametrium invasion was unilateral in 13.6% (n = 12) patients. Tumors involving the pelvic wall with associated hydronephrosis were present in 12.5% of cases (n = 11).</p><p>Lesions involving the bladder and/or rectum were present in 20.4% of cases (n = 18), as shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>. No patient had metastasis at the time of examination.</p><p>Concerning lymph node involvement, the internal and external iliac chains were invaded in 33.3% (n = 18 patients), followed by the retroperitoneal areas in 20.4% (n = 11).</p><p><xref ref-type="fig" rid="fig4">Figure 4</xref> and <xref ref-type="fig" rid="fig5">Figure 5</xref> present some illustrative stage of cervical cancer.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>Cervical cancer is the most common cancer in Cameroon, as well as the leading cause of cancer death in women, as in most sub-Saharan African countries, which do not have a nationwide mass screening program [<xref ref-type="bibr" rid="scirp.113385-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.113385-ref3">3</xref>].</p><sec id="s4_1"><title>4.1. Study Population</title><p>In our series, the mean age at diagnosis was 50.5 years. The age group most affected was 50 - 64 years (38.90%). This result is similar to that of Aboubacar Keita et al. who found an age of 52 years in Mali [<xref ref-type="bibr" rid="scirp.113385-ref7">7</xref>], and differs moderately from that of El Ghorfi in Morocco et al. who found an age of 59 years [<xref ref-type="bibr" rid="scirp.113385-ref6">6</xref>]. However, in general, the early onset of cancer in sub-Saharan Africa has already been highlighted by many authors [<xref ref-type="bibr" rid="scirp.113385-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.113385-ref8">8</xref>].</p><p>Most of our patients lived in rural areas (55.60%), as pointed out by Faye et al., who found a greater proportion of women living in rural areas (84.4%) in Senegal [<xref ref-type="bibr" rid="scirp.113385-ref9">9</xref>], the rural area is characterized by the scarcity of screening and awareness campaigns.</p></sec><sec id="s4_2"><title>4.2. Clinical Data</title><p>The major revealing sign was essentially metrorragia found in 92% of cases, which could be provoked or spontaneous. This result is similar to what Aboubacar et al. found in Mali metrorragia in 98.8% of cases [<xref ref-type="bibr" rid="scirp.113385-ref7">7</xref>].</p><p>According to our results, the delay of consultation is long, 55% of the patients consulted after 6 months of evolution, similar to the results of Kouskous et al. who found 57.9% in the city of Fez [<xref ref-type="bibr" rid="scirp.113385-ref10">10</xref>].</p></sec><sec id="s4_3"><title>4.3. Pelvic MRI Findings</title><p>The MRI maximum tumor diameter in this study was 52.9 mm (30 - 79 mm) on average. This differs slightly from the results of El Ghorfi et al., who founded 61 mm [<xref ref-type="bibr" rid="scirp.113385-ref6">6</xref>].</p><p>Although the estimation of tumor size remains clinical, MRI is of major contribution to improve the definition with an accuracy of 95% [<xref ref-type="bibr" rid="scirp.113385-ref4">4</xref>].</p><p>Paramedic invasion represented 72.2% of cases. Our data are similar to those of Kouskous et al. in Fez who found 68% parametrial invasion [<xref ref-type="bibr" rid="scirp.113385-ref10">10</xref>].</p><p>As pointed out by Shweel et al., parametrial invasion is an important criterion in the preoperative workup [<xref ref-type="bibr" rid="scirp.113385-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.113385-ref12">12</xref>]. However, there is a risk of overestimation due to peritumoral edema in the case of voluminous involvement [<xref ref-type="bibr" rid="scirp.113385-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.113385-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.113385-ref14">14</xref>].</p><p>MRI has a specificity of 97%, and a negative predictive value of 100% for parametrial invasion [<xref ref-type="bibr" rid="scirp.113385-ref15">15</xref>].</p><p>Regarding the classification used, which was that of IFOG, we obtained the following results: stage IA (9.10%), stage IB (10.20%), stage IIA (12.50%), stage IIB (29.50%), stage IIIA (5.70%), stage IIIB (12.50%), and stage IVA (20%).</p><p>Similar proportions in severe forms were found by Ghorfi et al. (32%) [<xref ref-type="bibr" rid="scirp.113385-ref6">6</xref>] and Shweel et al. in Egypt (26.6%) [<xref ref-type="bibr" rid="scirp.113385-ref11">11</xref>].</p><p>This similarity of severe forms could be explained by the difficulties encountered in the health systems of developing countries in terms of mass screening, particularly in Cameroon where 62.9% of cervical cancers are diagnosed at an advanced stage [<xref ref-type="bibr" rid="scirp.113385-ref16">16</xref>].</p><p>Concerning lymph node involvement, retroperitoneal areas were invaded in 20.4% of cases, which is a poor prognostic factor, and is equivalent to extrapelvic tumor extension (stage IVB), according to some authors [<xref ref-type="bibr" rid="scirp.113385-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.113385-ref17">17</xref>].</p><p>The limitation of this study was the small size of our sample, probably due to the monocentric nature of our work.</p></sec></sec><sec id="s5"><title>5. Conclusions</title><p>MRI has an important contribution to the evaluation of cervical cancer. It has been shown to complement the clinical examination by providing information on tumor size, parametrial invasion, adjacent organs involvement, and the presence of lymph node metastasis. Thus, MRI allows non-invasive is satisfactory in tumor staging.</p><p>Therefore, IRM is the reference examination for planning, choice of treatment, and search for possible tumor recurrence [<xref ref-type="bibr" rid="scirp.113385-ref7">7</xref>]. However, its relatively high cost and poor accessibility in our geographical context seem to be limiting factors, as in Cameroon.</p><p>A larger size of sample study would help to generalize our results in our context.</p></sec><sec id="s6"><title>Author Contributions</title><p>All authors contributed to the writing, read and approved the final version of the manuscript.</p></sec><sec id="s7"><title>Acknowledgements</title><p>We thank all the radiologists and technicians of the radiology department of the Military Hospital of Yaound&#233; who contributed to the collection of data analyzed in this study.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></sec><sec id="s9"><title>Cite this paper</title><p>Samuel, M.M., Onana, Y., Mohamadou, A., Amvene, J.M., Ngaroua, D., Secvou, G.E., Guena, M.N., Ayuk, O.F., Fouda, E., Zeh, O.F., Moifo, B., Ba, H. and Amvene, S.N. (2021) Contribution of MRI in Extension Assessment of Cervical Cancer in Yaound&#233; (Cameroon). Open Journal of Radiology, 11, 151-159. https://doi.org/10.4236/ojrad.2021.114014</p></sec></body><back><ref-list><title>References</title><ref id="scirp.113385-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Cancer. https://www.who.int/fr/news-room/fact-sheets/detail/cancer</mixed-citation></ref><ref id="scirp.113385-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Muteganya, D., Bigayi, T., Bigirimana, V., Sindayirwanya, J.B. and Marerwa, G. (1999) Cervical Cancer at Kamenge University Hospital about 35 Cases. Médecine d’Afrique Noire, 46, 153-156. http://www.santetropicale.com/Resume/34606.pdf</mixed-citation></ref><ref id="scirp.113385-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Tebeu, P.M., Antaon, J.S.S., Adjeba, M., Pikop, F., Fouogue, J.T. and Ndom, P. (2020) Knowledge, Attitudes and Practices of Health Professionals on Cervical Cancer in Cameroon. Public Health, 32, 489-496. https://doi.org/10.3917/spub.205.0489</mixed-citation></ref><ref id="scirp.113385-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Thille, A. (2004) Cervical Cancers: What Can MRI Do? Journal of Radiology, 85, 1366.  
https://doi.org/10.1016/S0221-0363(04)77185-1</mixed-citation></ref><ref id="scirp.113385-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">IGOF Classification of Cervical Carcinomas. https://screening.iarc.fr</mixed-citation></ref><ref id="scirp.113385-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">El Ghorfi, S. (2020) Contribution of MRI in the Assessment of Loco-Regional Extension of Cervical Cancer in 28 Cases.  
http://ao.um5.ac.ma/jspui/bitstream/123456789/18711/1/MS1762020.pdf</mixed-citation></ref><ref id="scirp.113385-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Balleyguier, C., Kinkel, K., Haie-Meder, C., Morice, P., Lhomme, C., Lumbroso, J., et al. (2004) Which Examinations Should Be Proposed for the Assessment of Extension and Follow-Up of Uterine Cervical Cancers: MRI, CT, PET-CT. Journal of Radiology, 85, 1190. https://doi.org/10.1016/S0221-0363(04)76605-6</mixed-citation></ref><ref id="scirp.113385-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Keita, A. (2020) Cervical Cancer: Therapeutic Aspect in the Radiotherapy Department of the H&amp;#244;pital du Mali. 
https://www.bibliosante.ml/bitstream/handle/123456789/3797/20M24.pdf</mixed-citation></ref><ref id="scirp.113385-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Alliance of Francophone African and Mediterranean Leagues against Cancer (2017) Cancer in Francophone Africa.  
https://www.iccp-portal.org/system/files/resources/LivreCancer.pdf</mixed-citation></ref><ref id="scirp.113385-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Faye, A., Mbengue, E.T. and Tal-Tal, A. (2017) Factors Associated with Cervical Cancer Screening in Rural Senegal. Journal of Epidemiology and Public Health, 65, S77.  
https://doi.org/10.1016/j.respe.2017.03.063</mixed-citation></ref><ref id="scirp.113385-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Kouskous, F. (2012) Cervical Cancer: Anatomopathological Studies (About 86 Cases). 
http://www.chu-fes.ma/cancer-du-col-uterin-etudes-anatomopathologiques-a-propos-de-86-cas</mixed-citation></ref><ref id="scirp.113385-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Shweel, M.A., Abdel-Gawad, E.A., Abdelghany, H.S., Abdel-Rahman, A.M. and Ibrahim, E.M. (2012) Uterine Cervical Malignancy: Diagnostic Accuracy of MRI with Histopathologic Correlation. Journal of Clinical Imaging Science, 2, 42.  
https://doi.org/10.4103/2156-7514.99175</mixed-citation></ref><ref id="scirp.113385-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Jena, A., Oberoi, R., Rawal, S., Das, S.K. and Pandey, K.K. (2005) Parametrial Invasion in Carcinoma of Cervix: Role of MRI Measured Tumour Volume. British Journal of Radiology, 78, 1075-1077. https://doi.org/10.1259/bjr/36116150</mixed-citation></ref><ref id="scirp.113385-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Nicolet, V., Carignan, L., Bourdon, F. and Prosmanne, O. (2000) MR Imaging of Cervical Carcinoma: A Practical Staging Approach. Radiographics, 20, 1539-1549.  
https://doi.org/10.1148/radiographics.20.6.g00nv111539</mixed-citation></ref><ref id="scirp.113385-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Sala, E., Wakely, S., Senior, E. and Lomas, D. (2007) MRI of Malignant Neoplasms of the Uterine Corpus and Cervix. American Journal of Roentgenology, 188, 1577-1587.  
https://doi.org/10.2214/AJR.06.1196</mixed-citation></ref><ref id="scirp.113385-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Sahdev, A., Sohaib, S.A., Wenaden, A.E.T., Shepherd, J.H. and Reznek, R.H. (2007) The Performance of Magnetic Resonance Imaging in Early Cervical Carcinoma: A Long-Term Experience. International Journal of Gynecological Cancer, 17, 629-636.  
https://doi.org/10.1111/j.1525-1438.2007.00829.x</mixed-citation></ref><ref id="scirp.113385-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Batoum, V.M., Sando, Z. and Nkegoum, B. (2020) Opportunistic Screening for Pre-Invasive Cervical Lesions and Cervical Cancer in Cameroonian Pregnant Women. Health Sciences and Disease. https://www.hsd-fmsb.org/index.php/hsd/article/view/1973</mixed-citation></ref></ref-list></back></article>